Stockscreener 앱 받기
4.23
2.67%
0.11
시간 외 거래:
4.15
-0.08
-1.89%
전일 마감가:
$4.12
열려 있는:
$4.06
하루 거래량:
378.54K
Relative Volume:
0.39
시가총액:
$189.74M
수익:
-
순이익/손실:
$-147.71M
주가수익비율:
-1.1797
EPS:
-3.5857
순현금흐름:
$-127.89M
1주 성능:
+4.70%
1개월 성능:
+12.50%
6개월 성능:
-76.54%
1년 성능:
-79.77%
1일 변동 폭
$4.05
$4.25
1주일 범위
$3.9875
$4.25
52주 변동 폭
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
명칭
Cargo Therapeutics Inc
전화
650-499-8950
주소
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
CRGX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.23 | 189.74M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-30 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2025-01-30 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-30 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2025-01-30 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-01-30 | 다운그레이드 | Truist | Buy → Hold |
| 2025-01-30 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-26 | 개시 | William Blair | Outperform |
| 2024-07-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-08 | 개시 | Chardan Capital Markets | Buy |
| 2024-06-27 | 개시 | Piper Sandler | Overweight |
| 2023-12-05 | 개시 | JP Morgan | Overweight |
| 2023-12-05 | 개시 | Jefferies | Buy |
| 2023-12-05 | 개시 | TD Cowen | Outperform |
| 2023-12-05 | 개시 | Truist | Buy |
모두보기
Cargo Therapeutics Inc 주식(CRGX)의 최신 뉴스
Swiss National Bank Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Brokers Offer Predictions for CRGX FY2025 Earnings - Defense World
Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Layoff Tracker: Lyndra’s Closure Expected To Cost 60 Employees Their Jobs - BioSpace
Biotech company based in Peninsula laying off 90% of staff - MSN
Finance Watch: Cargo Restructuring Not The News The IPO Market Needs - insights.citeline.com
California-Based Biotech Therapeutics Firm Lays Off 90% of Workforce - NewsBreak: Local News & Alerts
Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech
Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle
Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff - SFGATE
CARGO THERAPEUTICS Earnings Preview: Recent $CRGX Insider Trading, Hedge Fund Activity, and More - Nasdaq
90% Workforce Reduction Sent This Small Cap Soaring - The Globe and Mail
CARGO Stock Surges 19% Pre-Market After Suspending Development, Cutting 90% of Workforce - GuruFocus.com
Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit - Endpoints News
Cargo shelves cell therapy research, lays off more staff - BioPharma Dive
Cargo Lays Off 90% of Staff and Stops Development Work - BioSpace
CARGO Therapeutics (CRGX) Stock Climbs In Pre-Hour Market - Stocks Telegraph
After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more - Investing.com
Once-high-flying Cargo Therapeutics looks to ditch remaining work as CEO exitsSan Francisco Business Times - The Business Journals
Cargo Therapeutics provides corporate update -March 18, 2025 at 05:43 pm EDT - Marketscreener.com
CARGO Therapeutics halts development, cuts 90% of staff By Investing.com - Investing.com Australia
CARGO Therapeutics rises after hours on workforce reduction - MSN
CARGO Therapeutics halts development, cuts 90% of staff - Investing.com
CARGO Therapeutics Announces Major Workforce Reduction - TipRanks
Cargo suspends CRG-023 and allogeneic platform, reduces workforce by 90% - TipRanks
CARGO Therapeutics Suspends Development of CRG-023 and Allogeneic Platform, Appoints Interim CEO and Reduces Workforce by 90% - Nasdaq
CARGO Therapeutics Provides Corporate Update - The Bakersfield Californian
Major Shakeup: CARGO Therapeutics Ends All Programs Despite $368M Cash Position - StockTitan
William Blair Expects Weaker Earnings for CARGO Therapeutics - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
CARGO Therapeutics, Inc.: Hold Rating Amidst Developmental Stagnation and Future Prospects - TipRanks
CARGO Therapeutics (CRGX) to Release Quarterly Earnings on Thursday - Defense World
CARGO Therapeutics Inc. (CRGX) reports earnings - Quartz
Levi & Korsinsky Reminds Shareholders of an Investigation into CARGO Therapeutics, Inc. (CRGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Airline Stocks To Research – March 2nd - Defense World
Checkpoint Therapeutics: Pivoting From Approval To Gutsy Next Shot On Goal (NASDAQ:CKPT) - Seeking Alpha
CARGO Therapeutics: A Gutted CAR T Player Trying To Find New Direction (NASDAQ:CRGX) - Seeking Alpha
Lost Money on CARGO Therapeutics, Inc.(CRGX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Airline Stocks To Research – February 26th - Defense World
CARGO Therapeutics Discloses Strategic Corporate Presentation via SEC Filing - Defense World
Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, IncCRGX - PR Newswire
IPOs Numbers Rise In 2024 But Dwindling Returns Could Diminish Potential In 2025 - Citeline News & Insights
CARGO Therapeutics Highlights Progress in CAR T Therapy - TipRanks
Levi & Korsinsky Reminds CARGO Therapeutics, Inc. Investors of the Ongoing Investigation into Potential Violations of Securities LawsCRGX - ACCESS Newswire
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives $15.00 Consensus Target Price from Analysts - The AM Reporter
After Plunging -69.58% in 4 Weeks, Here's Why the Trend Might Reverse for CARGO Therapeutics, Inc. (CRGX) - Yahoo Finance
Cargo Therapeutics Inc (CRGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):